|
Volumn 4, Issue 7, 1997, Pages 273-282
|
Angiotensin II antagonists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 BUTYL 3 [[2 (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 3H IMIDAZO[4,5 B]PYRIDINE;
2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID;
2 ETHYL 4 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHOXY]QUINOLINE;
2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE;
5 [(3,5 DIBUTYL 1H 1,2,4 TRIAZOL 1 YL)METHYL] 2 [2 (1H TETRAZOL 5 YLPHENYL)]PYRIDINE;
AHA 756;
ANGIOTENSIN 2 RECEPTOR;
ANGIOTENSIN II ANTAGONIST;
BIBR 0277A;
CANDESARTAN;
CANDESARTAN HEXETIL;
CV 11974D;
EPROSARTAN;
FORASARTAN;
IMIDAZOLE DERIVATIVE;
IRBESARTAN;
LOSARTAN;
LOSARTAN POTASSIUM;
SARALASIN;
UNCLASSIFIED DRUG;
VALSARTAN;
ANGIOTENSIN BLOOD LEVEL;
AREA UNDER THE CURVE;
CARDIOVASCULAR DISEASE;
DOSE RESPONSE;
DRESSLER SYNDROME;
ENZYME ACTIVITY;
HEART FAILURE;
HEART LEFT VENTRICLE HYPERTROPHY;
HUMAN;
KIDNEY FAILURE;
MORTALITY;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
TISSUE DISTRIBUTION;
|
EID: 0030867193
PISSN: 09696113
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (50)
|